ATBECHDEDKESFRGBGRITLI..NLSE..PTIE......FI........*XDIM360 - Ver 2.9 (30 Jun 1998) 1100000/0 1710000/00998275A120000510EP97940797.01997090419990308EnEnEn24602 P19960905US20000510200019200005102000197 7A 61K 31/18 A 7A 61K 31/165 B 7A 61K 31/335 BdeINHIBITION DES NUKLEAREN TRANSKRIPTIONSFAKTORS NF-KAPPA-B DURCH KAFFEINSÄURE-PHENETYL-ESTER, DESSEN DERIVATE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMID) UND RESINIFERATOXINenINHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-kappaB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXINfrINHIBITION DU FACTEUR DE TRANSCRIPTION NUCLEAIRE NF-kappaB PAR L'ESTER PHENETHYLIQUE D'ACIDE CAFEIQUE, LES DERIVES DE CET ESTER, LA CAPSAICINE (8-METHYL-N-VANILLYLE-6-NONEAMIDE) ET LA RESINIFERATOXINENONERESEARCH DEVELOPMENT FOUNDATION01119572SJW/7879-EPFOUNDATION, RESEARCH DEVELOPMENT402 North Division StreetCarson CityNevada 89703USAGGARWAL, Bharat, B.3920 OberlinHouston, TX 77005USGRUNBERGER, Dezider,Inst. of Cancer Res.Columb. Univ.,116th Street at BroadwayNew York, NY 10032-2704USWilkinson, Stephen John00052061Stevens, Hewlett & Perkins1 St. Augustine's PlaceBristol BS1 4UDGBATBECHDEDKESFIFRGBGRIEITLINLPTSEUS971555119970904EnWO980962019980312199810